News Ranibizumab Treatment for Neovascular AMD by Medscape • 2014/02/26 • 0 Comments Are there risk factors for being a 'reduced responder' to ranibizumab treatment for AMD, and if so, what should clinicians be aware of? BMC Ophthalmology